AI summary · may contain errors
Fc-engineered broadly neutralizing antibodies with higher CD16 affinity (LPLIL and GASDALIE) significantly enhance ADCC against diverse HIV-1 subtypes despite cytokine-driven CD16 downregulation.
- 3 cites
Moving in mBio.
Rebuilt
AI summary · may contain errors
Fc-engineered broadly neutralizing antibodies with higher CD16 affinity (LPLIL and GASDALIE) significantly enhance ADCC against diverse HIV-1 subtypes despite cytokine-driven CD16 downregulation.
Newest first · last 60 days
AI summary · may contain errors
Once-weekly oral islatravir/lenacapavir is non-inferior to contemporary daily ART for maintaining virological suppression at 48 weeks in phase 3 ISLEND-1 and ISLEND-2 trials.
AI summary · may contain errors
Pyr01 selectively eliminates HIV-1-infected primary human monocyte-derived macrophages with an EC50 of ~0.36 μM, while the inactive analog Pyr02 shows minimal activity.
AI summary · may contain errors
In inner foreskin tissue from 116 HIV-negative Ugandan men, 48.6% of cells co-express CD4 and CCR5 with CD11c, identifying abundant HIV-susceptible dermal dendritic cells.
AI summary · may contain errors
CDRH2 lineage-modal state profiles differed between homologous and heterologous HIV-1 germline-targeting boosting regimens, with a regional profile statistic of 0.027066 (exact p = 0.001709).
AI summary · may contain errors
In the LCMV chronic infection model, TOX and PD-1 are required to maintain CXCR5+ TCF-1+ CD4 T cell precursors, preserving CD62L+ re-expansion potential.
AI summary · may contain errors
Four months of 30% caloric restriction in rhesus macaques reprograms metabolism and reduces acute SIV viremia after infection, with effects that wane over time.
AI summary · may contain errors
A CD19/HIV dual CAR T strategy in a humanized mouse leukemia model eradicated tumors comparable to CD19-only CAR T, while a CD19.BBζ-IL-18 plus CD4.28ζ-C34-CXCR4* design enhanced HIV and tumor control.
AI summary · may contain errors
In SIV mac239–infected rhesus macaques, post-treatment control after ART interruption required Env-specific rhesus IgG1 monoclonal antibodies, with robust latency reversal only in the ART+RhmAbs+CD8α-depletion+N-803 group.
AI summary · may contain errors
Human Plasma-Like Medium (HPLM) enhances HIV-1 infection in primary CD4 T cells compared with RPMI, while keeping activation and viral receptor expression similar.
AI summary · may contain errors
Modern antiretroviral therapy for HIV has improved efficacy, simplicity, dosing, and safety, but persistent myths about dosing, side effects, and lab testing still shape treatment decisions.
AI summary · may contain errors
A shared 101-gene “resolution signature” in core- and polymerase-specific CD8 T cells distinguishes functional cure from chronic hepatitis B, and entinostat improves T-cell function by increasing histone acetylation.
AI summary · may contain errors
A fully automated TTV-DNA qPCR assay with a 32.3 copies/ml limit of detection enables standardized longitudinal monitoring, revealing substantial intra- and inter-individual TTV load fluctuations in non-immunosuppressed subjects.
AI summary · may contain errors
In CD4+ T-cell models and primary CD4+ T cells from people living with HIV-1 on cART, inhibiting CDK12/CDK13–Cyclin K with SR-4835 robustly reversed HIV-1 latency without added stimuli.
AI summary · may contain errors
Thirteen cytokines are significantly higher in cerebrospinal fluid of virologically suppressed people with HIV (136 PWH) versus demographically matched people without HIV (30 PWoH), with p < 0.05.
AI summary · may contain errors
In primary CD4+ T cells from people living with HIV-1 on ART, HIV-1–infected and uninfected cells are lysed at identical rates under CTL-engaging single-chain diabodies, with no general resistance.
AI summary · may contain errors
X4 coreceptor–using HIV-1 in 1494 Netherlands adults on suppressive antiretroviral therapy is linked to larger HIV reservoirs, with median total HIV DNA 1051 vs 599 copies per 10^6 CD4+ T cells.
AI summary · may contain errors
In outbred rhesus macaques immunized with Q23-APEX-GT2, early autologous neutralization and B-cell priming efficiency predict post-infection serum breadth, with one animal neutralizing ~70% of tested viruses.
AI summary · may contain errors
Env-reactive B-cell responses show similar antibody function across simian-HIV infected rhesus macaques, despite highly diverse B-cell receptor genetics, especially for non-bnAbs.
AI summary · may contain errors
An NFAT-inducible lentiviral CRISPR-Cas9 system targeting HIV-1 gag, tat/rev, and CCR5 disrupts viral genome and replication in latently infected cell models.
AI summary · may contain errors
Oral uracil treatment in rhesus macaques increases susceptibility to intra-rectal SIVmac239X acquisition, while uracil suppositories do not.
Journals this month
Topics moving, week to 17 Nov 2026
By field